GALMED PHARMACEUTICALS LTD's ticker is GLMD and the CUSIP is M47238106. A total of 35 filers reported holding GALMED PHARMACEUTICALS LTD in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $26,000 | – | 4,629 | +10186.7% | 0.00% | – |
| Q3 2019 | $0 | -100.0% | 45 | -99.9% | 0.00% | – |
| Q2 2019 | $237,000 | -11.2% | 32,300 | -1.5% | 0.00% | – |
| Q1 2019 | $267,000 | +16.6% | 32,800 | -2.4% | 0.00% | – |
| Q4 2018 | $229,000 | -42.5% | 33,600 | -53.1% | 0.00% | – |
| Q1 2018 | $398,000 | +61.8% | 71,585 | +165.6% | 0.00% | – |
| Q4 2017 | $246,000 | +969.6% | 26,949 | +418.2% | 0.00% | – |
| Q2 2016 | $23,000 | -20.7% | 5,200 | +65.7% | 0.00% | – |
| Q1 2015 | $29,000 | -85.1% | 3,139 | -84.3% | 0.00% | – |
| Q2 2014 | $194,000 | -15.3% | 20,000 | 0.0% | 0.00% | – |
| Q1 2014 | $229,000 | – | 20,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ibex Investors LLC | 418,000 | $5,676,000 | 3.15% |
| Knoll Capital Management, LLC | 210,000 | $2,881,000 | 2.44% |
| BVF INC/IL | 1,761,567 | $23,922,000 | 2.10% |
| P.A.W. CAPITAL CORP | 90,000 | $1,222,000 | 1.30% |
| 683 Capital Management, LLC | 1,350,000 | $18,333,000 | 1.19% |
| Vivo Capital, LLC | 851,492 | $11,563,000 | 1.16% |
| MEITAV INVESTMENT HOUSE LTD | 653,957 | $8,946,000 | 0.44% |
| Trellus Management Company, LLC | 16,711 | $227,000 | 0.33% |
| Nantahala Capital Management | 838,674 | $11,389,000 | 0.31% |
| MENTA CAPITAL LLC | 49,183 | $668,000 | 0.23% |